CRP and Parkinson disease: There are a few references to the use of salival Abeta42 in diagnosing AD [13,14], of saliva alpha-synuclein as a biomarker for Parkinson’s disease [15] and progressive supranuclear palsy [16], and quite a few on saliva levels of CRP in heart disease and atherosclerosis I [17,18].